You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Remodelling intravitreal therapy pathways for macular disease during the COVID-19 pandemic and an Austrian national lockdown

Article metrics

Article menu

Download PDFPDF

XML
Original research
Remodelling intravitreal therapy pathways for macular disease during the COVID-19 pandemic and an Austrian national lockdown

 

Online download statistics by month:

Online download statistics by month: September 2020 to March 2024

AbstractFullPdf
Sep 202016316318
Oct 202013513020
Nov 20201009713
Dec 202012912313
Jan 202123823624
Feb 2021888811
Mar 202146467
Apr 202140357
May 202119178
Jun 2021333011
Jul 2021565616
Aug 202122229
Sep 202127247
Oct 2021272319
Nov 2021434229
Dec 2021302611
Jan 202221188
Feb 202214164
Mar 202217176
Apr 202233346
May 2022425118
Jun 202233327
Jul 202218164
Aug 202225223
Sep 202226309
Oct 2022332910
Nov 202218161
Dec 20221093
Jan 202316148
Feb 2023363615
Mar 202323227
Apr 202310106
May 202314158
Jun 202310102
Jul 202312125
Aug 2023993
Sep 2023983
Oct 202311112
Nov 202310100
Dec 202315152
Jan 202421181
Feb 202413134
Mar 202419193
Total17141670371